May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Clinicians’ Agreement in Establishing Glaucomatous Progression Using the HRT Topographic Change Analysis (TCA), Trend Analysis (TA) and Moorfields Regression Analysis (MRA)
Author Affiliations & Notes
  • G. Vizzeri
    Hamilton Glaucoma Center, Dept. of Ophthalmology, University of California, San Diego, La Jolla, California
  • J. M. Martinez de la Casa
    Ophthalmology, Hospital Clinico San Carlos, Madrid, Spain
    Universidad Complutense, Madrid, Spain
  • L. M. Alencar
    Hamilton Glaucoma Center, Dept. of Ophthalmology, University of California, San Diego, La Jolla, California
    Department of Ophthalmology, University of São Paulo, São Paulo, Brazil
  • C. Bowd
    Hamilton Glaucoma Center, Dept. of Ophthalmology, University of California, San Diego, La Jolla, California
  • M. Balasubramanian
    Hamilton Glaucoma Center, Dept. of Ophthalmology, University of California, San Diego, La Jolla, California
  • F. A. Medeiros
    Hamilton Glaucoma Center, Dept. of Ophthalmology, University of California, San Diego, La Jolla, California
  • R. N. Weinreb
    Hamilton Glaucoma Center, Dept. of Ophthalmology, University of California, San Diego, La Jolla, California
  • L. M. Zangwill
    Hamilton Glaucoma Center, Dept. of Ophthalmology, University of California, San Diego, La Jolla, California
  • Footnotes
    Commercial Relationships  G. Vizzeri, None; J.M. Martinez de la Casa, None; L.M. Alencar, None; C. Bowd, Lace Elettronica, F; M. Balasubramanian, Heidelberg Engineering, F; F.A. Medeiros, Carl Zeiss Meditec, F; Heidelberg Engineering, F; Carl Zeiss Meditec, R; Reichart Instruments, R; R.N. Weinreb, Carl Zeiss Meditec, F; Heidelberg Engineering, F; Carl Zeiss Meditec, C; L.M. Zangwill, Carl Zeiss Meditec, F; Heidelberg Engineering, F; Optovue, F.
  • Footnotes
    Support  NEI EY011008, Participant incentive grants in the form of glaucoma medication at no cost from Alcon Laboratories Inc., Allergan, Pfizer Inc. and SANTEN Inc.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 3653. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G. Vizzeri, J. M. Martinez de la Casa, L. M. Alencar, C. Bowd, M. Balasubramanian, F. A. Medeiros, R. N. Weinreb, L. M. Zangwill; Clinicians’ Agreement in Establishing Glaucomatous Progression Using the HRT Topographic Change Analysis (TCA), Trend Analysis (TA) and Moorfields Regression Analysis (MRA). Invest. Ophthalmol. Vis. Sci. 2008;49(13):3653. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To assess the degree of concordance among clinicians reviewing three HRT printouts to detect progression, the TCA, the TA and the MRA, and to compare the results with progression by stereophotographs.

Methods: : Three experienced observers (GV, JMC and LA) judged the presence of progression using the HRT follow-up printouts available for each HRT method of analysis (TCA, TA, MRA). The overall assessment was based on majority rule, with at least two graders agreeing on the classification. Agreement for progression or no progression between the HRT methods of analysis and the reference standard represented by stereophotographs was also evaluated. The kappa test was used to assess the interobserver agreement.

Results: : 136 eyes of 112 patients (53 glaucomatous eyes, 83 glaucoma suspects) from the Diagnostic Innovations in Glaucoma Study (DIGS) were followed up longitudinally for 50.8 (S.D.= 11.1) months, with a minimum of 4 HRT images (range 4-7). 16 of 136 (11.8%) eyes were found to progress during follow-up based on stereophotographs assessment. Agreement among clinicians for subjective assessment of progression was fair to moderate, with better agreement for TCA and TA than for the MRA analysis (kappas ranging from 0.28 to 0.5 for MRA, 0.36 to 0.53 for TCA and 0.26 to 0.61 for TA). Agreement for progression/no progression between the HRT methods and stereophotography was similar for TCA, (75%, agreement on 6 progressing eyes and 96 non progressing eyes, kappa= 0.13), TA (74%, agreement on 4 progressing eyes and 97 non progressing eyes, kappa= 0.04) and MRA (76%, agreement on 2 progressing eyes and 102 non progressing eyes, kappa= -0.02).

Conclusions: : Clinicians’ agreement in establishing glaucomatous progression using different HRT methods of analysis was only fair to moderate and was better for the methods originally designed to detect progression (TCA and TA) than MRA, which is not designed to detect progression but is likely used for this purpose. Agreement between TCA and stereophotographs was similar to previous reports. Further studies are needed to establish predefined objective criteria for detecting change over time that can be used to assess progression with HRT in clinical practice.

Keywords: imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • optic disc • imaging/image analysis: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×